News
Media
Conferences
Events
Partners
Publications
Resources
Biomarker Consortium
Subscribe

Elizabeth H. Stover, MD, PhD

Articles by Elizabeth H. Stover, MD, PhD

Ursula A. Matulonis, MD, chief, Division of Gynecologic Oncology, Brock-Wilcon Family Chair, Dana-Farber Cancer Institute, professor, medicine, Harvard Medical School; Elizabeth H. Stover, MD, PhD, physician, Dana-Farber Cancer Institute, assistant professor of medicine, Harvard Medical School

RAS/MAP Kinase Pathway Targeting Makes Strides in Gynecologic Cancer Management: With Ursula A. Matulonis, MD; and Elizabeth H. Stover, MD, PhD

ByUrsula A. Matulonis, MD,Elizabeth H. Stover, MD, PhD

April 24th 2026

Drs Matulonis and Stover explore the biology and therapeutic relevance of the RAS/MAP kinase pathway in gynecologic cancers.

Latest Updated Articles

Trending on OncLive

Targeted Therapies, ADCs, and Oral SERD Combos Expand Treatment Possibilities Across Breast Cancer Settings

Head and Neck Oncologists Highlight Practice-Informing Research From ASCO 2026

Dr Galsky on the Current Roles of Biomarkers in Bladder Cancer

Sonrotoclax Plus Zanubrutinib Yields High Undetectable MRD Rates in Treatment-Naive CLL/SLL

FDA Grants Priority Review to Adjuvant Atezolizumab Plus Chemotherapy for Stage III dMMR Colon Cancer